{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:45:00Z","timestamp":1790844300520,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Merck (Canada)"},{"name":"Merck (Canada)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2185-3","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T14:03:56Z","timestamp":1484316236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia"],"prefix":"10.1186","volume":"17","author":[{"given":"Kevin J.","family":"Friesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Alessi-Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Bugden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"2185_CR1","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9\u201320.","journal-title":"Proc R Soc Med"},{"issue":"1 Suppl 1","key":"2185_CR2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2007.10.002","volume":"9","author":"KE Schmader","year":"2008","unstructured":"Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain. 2008;9(1 Suppl 1):S3\u20139.","journal-title":"J Pain"},{"issue":"5","key":"2185_CR3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann","year":"2002","unstructured":"Gnann JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340\u20136.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2185_CR4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","volume":"48","author":"AA Gershon","year":"2010","unstructured":"Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010;48 Suppl 1:S2\u20137.","journal-title":"J Clin Virol"},{"issue":"3","key":"2185_CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2008.03.011","volume":"26","author":"NH Mueller","year":"2008","unstructured":"Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008;26(3):675\u201397.","journal-title":"Neurol Clin"},{"issue":"Suppl 1","key":"2185_CR6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","volume":"44","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44 Suppl 1:S1\u2013S26.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2185_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","volume":"127","author":"M Brisson","year":"2001","unstructured":"Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001;127(2):305\u201314.","journal-title":"Epidemiol Infect"},{"issue":"Suppl 3","key":"2185_CR8","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1093\/infdis\/174.Supplement_3.S314","volume":"174","author":"CK Fairley","year":"1996","unstructured":"Fairley CK, Miller E. Varicella-zoster virus epidemiology--a changing scene? J Infect Dis. 1996;174 Suppl 3:S314\u20139.","journal-title":"J Infect Dis"},{"issue":"4","key":"2185_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2051013615599151","volume":"3","author":"RW Johnson","year":"2015","unstructured":"Johnson RW, Alvarez-Pasquin M-J, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccin. 2015;3(4):109\u201320.","journal-title":"Ther Adv Vaccin"},{"issue":"3","key":"2185_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","volume":"125","author":"M Brisson","year":"2000","unstructured":"Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125(3):651\u201369.","journal-title":"Epidemiol Infect"},{"key":"2185_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/JPR.S57242","volume":"7","author":"JS Massengill","year":"2014","unstructured":"Massengill JS, Kittredge JL. Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider. J Pain Res. 2014;7:125\u201332.","journal-title":"J Pain Res"},{"issue":"11","key":"2185_CR12","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1346-8138.2012.01584.x","volume":"39","author":"F Ono","year":"2012","unstructured":"Ono F, Yasumoto S, Furumura M, et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster. J Dermatol. 2012;39(11):902\u20138.","journal-title":"J Dermatol"},{"key":"2185_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1471-2334-10-230","volume":"10","author":"LE Gialloreti","year":"2010","unstructured":"Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis. 2010;10:230.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2185_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","volume":"14","author":"B Ultsch","year":"2013","unstructured":"Ultsch B, K\u00f6ster I, Reinhold T, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ. 2013;14(6):1015\u201326.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"2185_CR15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","volume":"137","author":"A Gauthier","year":"2009","unstructured":"Gauthier A, Breuer J, Carrington D, Martin M, R\u00e9my V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38\u201347.","journal-title":"Epidemiol Infect"},{"issue":"Suppl 2","key":"2185_CR16","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","volume":"197","author":"MN Oxman","year":"2008","unstructured":"Oxman MN, Levin MJ. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197 Suppl 2:S228\u201336.","journal-title":"J Infect Dis"},{"issue":"5","key":"2185_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jinf.2013.06.016","volume":"67","author":"D Weitzman","year":"2013","unstructured":"Weitzman D, Shavit O, Stein M, Cohen R, Chodick G, Shalev V. A population based study of the epidemiology of herpes zoster and its complications. J Infect. 2013;67(5):463\u20139.","journal-title":"J Infect"},{"issue":"1","key":"2185_CR18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2334-11-302","volume":"11","author":"AM Cebri\u00e1n-Cuenca","year":"2011","unstructured":"Cebri\u00e1n-Cuenca AM, D\u00edez-Domingo J, San-Mart\u00edn-Rodr\u00edguez M, Puig-Barber\u00e1 J, Navarro-P\u00e9rez J. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis. 2011;11(1):302.","journal-title":"BMC Infect Dis"},{"issue":"23\u201324","key":"2185_CR19","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","volume":"19","author":"WJ Edmunds","year":"2001","unstructured":"Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19(23\u201324):3076\u201390.","journal-title":"Vaccine"},{"issue":"9","key":"2185_CR20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113\u2013e88.","journal-title":"Eur J Neurol"},{"issue":"6","key":"2185_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","volume":"19","author":"D Moulin","year":"2014","unstructured":"Moulin D, Boulanger A, Clark AJ, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian pain society. Pain Res Manag. 2014;19(6):328\u201335.","journal-title":"Pain Res Manag"},{"issue":"10","key":"2185_CR22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","volume":"55","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Oxman MN, Levin MJ, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis. 2012;55(10):1320\u20138.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"2185_CR23","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271\u201384.","journal-title":"N Engl J Med"},{"key":"2185_CR24","unstructured":"Drug Products Database. Health Canada website. http:\/\/webprod5.hc-sc.gc.ca\/dpd-bdpp\/index-eng.jsp . Accessed 9 Jan 2017."},{"issue":"11","key":"2185_CR25","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","volume":"140","author":"J Bilcke","year":"2012","unstructured":"Bilcke J, Ogunjimi B, Marais C, et al. The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect. 2012;140(11):2096\u2013109.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"2185_CR26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12879-015-1059-9","volume":"15","author":"C Blein","year":"2015","unstructured":"Blein C, Gavazzi G, Paccalin M, Baptiste C, Berrut G, Vainchtock A. Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50\u00a0years in France. BMC Infect Dis. 2015;15(1):350.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2185_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-11-173","volume":"11","author":"B Ultsch","year":"2011","unstructured":"Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11(1):173.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2185_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2296-12-136","volume":"12","author":"CD Lionis","year":"2011","unstructured":"Lionis CD, Vardavas CI, Symvoulakis EK, et al. Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece. BMC Fam Pract. 2011;12(1):136.","journal-title":"BMC Fam Pract"},{"issue":"43","key":"2185_CR29","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","volume":"25","author":"V Legami Di","year":"2007","unstructured":"Di Legami V, Gianino MM, Atti MCD, et al. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine. 2007;25(43):7598\u2013604.","journal-title":"Vaccine"},{"key":"2185_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.socscimed.2007.08.017","volume":"66","author":"LL Roos","year":"2008","unstructured":"Roos LL, Brownell M, Lix L, Roos NP, Walld R, Macwilliam L. From health research to social research : privacy, methods, approaches. Soc Sci Med. 2008;66:117\u201329.","journal-title":"Soc Sci Med"},{"key":"2185_CR31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-publhealth-031210-100700","volume":"32","author":"DP Jutte","year":"2011","unstructured":"Jutte DP, Roos LL, Brownell MD. Administrative record linkage as a tool for public health research. Annu Rev Public Health. 2011;32:91\u2013108.","journal-title":"Annu Rev Public Health"},{"issue":"12","key":"2185_CR32","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4065\/mcp.2011.0305","volume":"86","author":"M Klompas","year":"2011","unstructured":"Klompas M, Kulldorff M, Vilk Y, Bialek SR, Harpaz R. Herpes zoster and postherpetic neuralgia surveillance using structured electronic data. Mayo Clin Proc. 2011;86(12):1146\u201353.","journal-title":"Mayo Clin Proc"},{"key":"2185_CR33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/JPR.S107944","volume":"9","author":"KJ Friesen","year":"2016","unstructured":"Friesen KJ, Falk J, Alessi-severini S, Chateau D, Bugden S. Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia. J Pain Res. 2016;9:543\u201350.","journal-title":"J Pain Res"},{"issue":"19\u201320","key":"2185_CR34","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","volume":"20","author":"M Brisson","year":"2002","unstructured":"Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 2002;20(19\u201320):2500\u20137.","journal-title":"Vaccine"},{"issue":"5 Pt 1","key":"2185_CR35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(98)70207-5","volume":"38","author":"BA Solomon","year":"1998","unstructured":"Solomon BA, Kaporis AG, Glass AT, Simon SI, Baldwin HE. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). J Am Acad Dermatol. 1998;38(5 Pt 1):763\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"9334","key":"2185_CR36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","volume":"360","author":"SL Thomas","year":"2002","unstructured":"Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case\u2013control study. Lancet. 2002;360(9334):678\u201382.","journal-title":"Lancet"},{"issue":"6","key":"2185_CR37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S0950268811001786","volume":"140","author":"DY Chao","year":"2012","unstructured":"Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000\u20132008. Epidemiol Infect. 2012;140(6):1131\u201340.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"2185_CR38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jinf.2002.0988","volume":"44","author":"WJ Edmunds","year":"2002","unstructured":"Edmunds WJ, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect. 2002;44(4):211\u20139.","journal-title":"J Infect"},{"issue":"47","key":"2185_CR39","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.vaccine.2013.09.018","volume":"32","author":"ML Russell","year":"2014","unstructured":"Russell ML, Dover DC, Simmonds KA, Svenson LW. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014;32(47):6319\u201324.","journal-title":"Vaccine"},{"issue":"47","key":"2185_CR40","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","volume":"29","author":"P Tanuseputro","year":"2011","unstructured":"Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29(47):8580\u20134.","journal-title":"Vaccine"},{"issue":"3","key":"2185_CR41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","volume":"52","author":"J Leung","year":"2011","unstructured":"Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the united states, 1993\u20132006: Evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52(3):332\u201340.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2185_CR42","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","volume":"8","author":"B Ogunjimi","year":"2013","unstructured":"Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS One. 2013;8(6):e66485.","journal-title":"PLoS One"},{"key":"2185_CR43","unstructured":"Hilderman T, Katz A, Derksen S, et al. Manitoba immunization study. Winnipeg: Manitoba Centre for Health Policy; 2011. http:\/\/mchp-appserv.cpe.umanitoba.ca\/reference\/MB_Immunization_Report_WEB.pdf . Accessed 9 Jan 2017."},{"key":"2185_CR44","unstructured":"Government of Ontario. Ontario\u2019s Routine Immunization Schedule. http:\/\/www.health.gov.on.ca\/en\/public\/programs\/immunization\/static\/immunization_tool.html . Published 2016. Accessed 9 Jan 2017."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:12:00Z","timestamp":1498378320000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2185-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2185-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"69"}}